Mather Group LLC. Has $1.06 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mather Group LLC. boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 49.7% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 2,371 shares of the medical equipment provider’s stock after purchasing an additional 787 shares during the period. Mather Group LLC.’s holdings in Intuitive Surgical were worth $1,055,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Provence Wealth Management Group bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $276,000. Sequoia Financial Advisors LLC raised its holdings in shares of Intuitive Surgical by 58.0% during the 4th quarter. Sequoia Financial Advisors LLC now owns 8,315 shares of the medical equipment provider’s stock worth $2,805,000 after buying an additional 3,054 shares in the last quarter. Public Employees Retirement System of Ohio lifted its position in shares of Intuitive Surgical by 5.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 191,283 shares of the medical equipment provider’s stock worth $64,531,000 after buying an additional 9,869 shares during the last quarter. HCR Wealth Advisors boosted its stake in Intuitive Surgical by 26.3% in the fourth quarter. HCR Wealth Advisors now owns 1,042 shares of the medical equipment provider’s stock valued at $352,000 after buying an additional 217 shares in the last quarter. Finally, Kades & Cheifetz LLC bought a new position in Intuitive Surgical in the fourth quarter valued at about $230,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded up $11.35 during trading hours on Wednesday, reaching $459.01. The stock had a trading volume of 569,154 shares, compared to its average volume of 1,566,855. The company has a 50 day moving average price of $433.72 and a two-hundred day moving average price of $402.67. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $468.78. The stock has a market capitalization of $162.81 billion, a PE ratio of 80.81, a PEG ratio of 4.97 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter in the prior year, the firm posted $1.18 EPS. Intuitive Surgical’s quarterly revenue was up 14.5% compared to the same quarter last year. Equities research analysts predict that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently weighed in on ISRG. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price objective for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Piper Sandler boosted their price target on Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a report on Friday, April 19th. Finally, Citigroup increased their price target on Intuitive Surgical from $462.00 to $512.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $442.30.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 175 shares of the stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $389.16, for a total value of $68,103.00. Following the transaction, the senior vice president now owns 883 shares of the company’s stock, valued at $343,628.28. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, insider Gary S. Guthart 7,440 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, July 30th. The was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Mark Brosius sold 175 shares of Intuitive Surgical stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $68,103.00. Following the completion of the transaction, the senior vice president now directly owns 883 shares in the company, valued at approximately $343,628.28. The disclosure for this sale can be found here. Insiders sold 16,005 shares of company stock worth $6,894,422 in the last 90 days. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.